Successful treatment of acquired von Willebrand disease with lenalidomide leading to dramatic resolution of intractable gastrointestinal bleeding: A case report

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Haemophilia

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/hae.13464PMID 29578269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy

  2016cited by this paper
• Thalidomide for treatment of gastrointestinal bleedings due to angiodysplasia: a case report in acquired von Willebrand syndrome and review of the literature

  2015cited by this paper
• Treatment of Acquired von Willebrand Syndrome and Prevention of Bleeding Postautologous Stem Cell Transplant during Severe Pancytopenia with IVIG

  2015cited by this paper
• Von Willebrand disease‐associated angiodysplasia: a few answers, still many questions

  2013cited by this paper
• How I treat the acquired von Willebrand syndrome.

  2011cited by this paper
• Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?

  2009cited by this paper
• Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens.

  2008cited by this paper
• Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding.

  2007cited by this paper
• Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects

  2002cited by this paper

• Acquired von Willebrand syndrome in a patient with monoclonal gammopathy of unknown significance: A case report

  2024cites this paper
• Acquired von Willebrand Syndrome Associated with a Smoldering Multiple Myeloma, Successfully Treated by Daratumumab, Lenalidomide, and Dexamethasone

  2024cites this paper
• Acquired von Willebrand syndrome and lymphoid neoplasms: A review of malignancy management, and propositions of practical recommendations

  2022cites this paper
• Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy

  2022cites this paper
• Unusual Manifestations of Paraprotein-Associated Hematological Diseases: Report of 2 Cases and Literature Review

  2021cites this paper
• Erworbene Hemmkörperhämophilie

  2020cites this paper
• HOW I TREAT GASTRO-INTESTINAL BLEEDING IN CONGENITAL AND ACQUIRED VON WILLEBRAND DISEASE.

  2020cites this paper
• Lenalidomide

  2018cites this paper